FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W43843458> ?p ?o ?g. }

• W43843458 endingPage "685" @default.
• W43843458 startingPage "678" @default.
• W43843458 abstract "We evaluated the efficacy and safety of prasugrel and clopidogrel in the setting of a glycoprotein (GP) IIb/IIIa inhibitor. Prasugrel reduced cardiovascular events as compared with clopidogrel in TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38) but with increased bleeding. Researchers in the TRITON–TIMI 38 randomized 13,608 subjects with acute coronary syndrome undergoing percutaneous coronary intervention to prasugrel versus clopidogrel. The use of a GP IIb/IIIa inhibitor was at the physician's discretion. For the current analysis, end points were examined at 30 days and were stratified by use of a GP IIb/IIIa inhibitor. A total of 7,414 subjects (54.5%) received a GP IIb/IIIa inhibitor during their index hospitalization. There was a consistent benefit of prasugrel over clopidogrel for reducing cardiovascular death, myocardial infarction, or stroke in patients who did (hazard ratio: 0.76; 95% confidence interval: 0.64 to 0.90) or did not receive a GP IIb/IIIa inhibitor (hazard ratio: 0.78; 95% confidence interval: 0.63 to 0.97, pinteraction= 0.83). Prasugrel significantly reduced myocardial infarction, urgent revascularization, and stent thrombosis irrespective of GP IIb/IIIa inhibitor use. Although subjects treated with a GP IIb/IIIa inhibitor had greater rates of bleeding, the risk of Thrombolysis in Myocardial Infarction major or minor bleeding with prasugrel versus clopidogrel was not significantly different in patients who were or were not treated with GP IIb/IIIa inhibitor (pinteraction= 0.19). Prasugrel significantly reduces the risk of cardiovascular events in patients with acute coronary syndromes after percutaneous coronary intervention regardless of whether or not a GP IIb/IIIa inhibitor is used. The use of a GP IIb/IIIa inhibitor does not accentuate the relative risk of bleeding with prasugrel as compared with clopidogrel." @default.
• W43843458 created "2016-06-24" @default.
• W43843458 creator A5003831287 @default.
• W43843458 creator A5012922168 @default.
• W43843458 creator A5019382226 @default.
• W43843458 creator A5019612250 @default.
• W43843458 creator A5020677154 @default.
• W43843458 creator A5022267024 @default.
• W43843458 creator A5030057930 @default.
• W43843458 creator A5030063582 @default.
• W43843458 creator A5054104503 @default.
• W43843458 creator A5081943616 @default.
• W43843458 creator A5085897222 @default.
• W43843458 date "2009-08-01" @default.
• W43843458 modified "2023-09-30" @default.
• W43843458 title "The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention" @default.
• W43843458 cites W1985059672 @default.
• W43843458 cites W1985835171 @default.
• W43843458 cites W2005726649 @default.
• W43843458 cites W200979310 @default.
• W43843458 cites W2011909727 @default.
• W43843458 cites W2049120615 @default.
• W43843458 cites W2057395242 @default.
• W43843458 cites W2116457054 @default.
• W43843458 cites W2119860290 @default.
• W43843458 cites W2131370832 @default.
• W43843458 cites W2131450595 @default.
• W43843458 cites W2132067789 @default.
• W43843458 cites W2138696762 @default.
• W43843458 cites W2143118485 @default.
• W43843458 cites W2144095528 @default.
• W43843458 cites W2147746835 @default.
• W43843458 cites W2152823642 @default.
• W43843458 cites W2157123954 @default.
• W43843458 cites W2161471033 @default.
• W43843458 cites W2169387542 @default.
• W43843458 cites W2230838014 @default.
• W43843458 cites W2600985212 @default.
• W43843458 cites W4256202725 @default.
• W43843458 cites W906589 @default.
• W43843458 doi "https://doi.org/10.1016/j.jacc.2009.05.025" @default.
• W43843458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19679245" @default.
• W43843458 hasPublicationYear "2009" @default.
• W43843458 type Work @default.
• W43843458 sameAs 43843458 @default.
• W43843458 citedByCount "108" @default.
• W43843458 countsByYear W438434582012 @default.
• W43843458 countsByYear W438434582013 @default.
• W43843458 countsByYear W438434582014 @default.
• W43843458 countsByYear W438434582015 @default.
• W43843458 countsByYear W438434582016 @default.
• W43843458 countsByYear W438434582017 @default.
• W43843458 countsByYear W438434582018 @default.
• W43843458 countsByYear W438434582019 @default.
• W43843458 countsByYear W438434582020 @default.
• W43843458 countsByYear W438434582021 @default.
• W43843458 countsByYear W438434582022 @default.
• W43843458 crossrefType "journal-article" @default.
• W43843458 hasAuthorship W43843458A5003831287 @default.
• W43843458 hasAuthorship W43843458A5012922168 @default.
• W43843458 hasAuthorship W43843458A5019382226 @default.
• W43843458 hasAuthorship W43843458A5019612250 @default.
• W43843458 hasAuthorship W43843458A5020677154 @default.
• W43843458 hasAuthorship W43843458A5022267024 @default.
• W43843458 hasAuthorship W43843458A5030057930 @default.
• W43843458 hasAuthorship W43843458A5030063582 @default.
• W43843458 hasAuthorship W43843458A5054104503 @default.
• W43843458 hasAuthorship W43843458A5081943616 @default.
• W43843458 hasAuthorship W43843458A5085897222 @default.
• W43843458 hasConcept C126322002 @default.
• W43843458 hasConcept C164705383 @default.
• W43843458 hasConcept C207103383 @default.
• W43843458 hasConcept C2777028646 @default.
• W43843458 hasConcept C2777698277 @default.
• W43843458 hasConcept C2777849778 @default.
• W43843458 hasConcept C2777995511 @default.
• W43843458 hasConcept C2780400711 @default.
• W43843458 hasConcept C44249647 @default.
• W43843458 hasConcept C500558357 @default.
• W43843458 hasConcept C71924100 @default.
• W43843458 hasConceptScore W43843458C126322002 @default.
• W43843458 hasConceptScore W43843458C164705383 @default.
• W43843458 hasConceptScore W43843458C207103383 @default.
• W43843458 hasConceptScore W43843458C2777028646 @default.
• W43843458 hasConceptScore W43843458C2777698277 @default.
• W43843458 hasConceptScore W43843458C2777849778 @default.
• W43843458 hasConceptScore W43843458C2777995511 @default.
• W43843458 hasConceptScore W43843458C2780400711 @default.
• W43843458 hasConceptScore W43843458C44249647 @default.
• W43843458 hasConceptScore W43843458C500558357 @default.
• W43843458 hasConceptScore W43843458C71924100 @default.
• W43843458 hasIssue "8" @default.
• W43843458 hasLocation W438434581 @default.
• W43843458 hasLocation W438434582 @default.
• W43843458 hasOpenAccess W43843458 @default.
• W43843458 hasPrimaryLocation W438434581 @default.
• W43843458 hasRelatedWork W2004017808 @default.
• W43843458 hasRelatedWork W2325312573 @default.

• next